NCT01169181View on ClinicalTrials.gov

AMES + Brain Stimulation

PHASE1UnknownINTERVENTIONAL

Enrollment

6

Participants

Timeline

Start Date

July 31, 2010

Primary Completion Date

December 31, 2018

Study Completion Date

December 31, 2019

Conditions

StrokeCerebrovascular AccidentPlegia

Interventions

DEVICE

AMES + brain stimulation

Stroke survivors with plegia of affected upper extremity receive either AMES + rTMS or AMES + tDCS.

Trial Locations (1)

97239

Oregon Health and Science University, Portland

Sponsors

Lead Sponsor

AMES Technology

All Listed Sponsors

collaborator

National Institute of Neurological Disorders and Stroke (NINDS)

NIH

lead

AMES Technology

INDUSTRY

NCT01169181 - AMES + Brain Stimulation | Biotech Hunter | Biotech Hunter